135604-76-1

Basic information

• Product Name: (5Z,7E)-(1S,3R)-1,3-bis<(t-butyldimethylsilyl)oxy>-9,10-secochola-5,7,10(19)-trien-24-al
• Synonyms: (5Z,7E)-(1S,3R)-1,3-bis<(t-butyldimethylsilyl)oxy>-9,10-secochola-5,7,10(19)-trien-24-al
• CAS NO: 135604-76-1
• Molecular Weight: 601.073
• Mol File: 135604-76-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (5Z,7E)-(1S,3R)-1,3-bis<(t-butyldimethylsilyl)oxy>-9,10-secochola-5,7,10(19)-trien-24-al(CAS DataBase Reference)
• NIST Chemistry Reference: (5Z,7E)-(1S,3R)-1,3-bis<(t-butyldimethylsilyl)oxy>-9,10-secochola-5,7,10(19)-trien-24-al(135604-76-1)
• EPA Substance Registry System: (5Z,7E)-(1S,3R)-1,3-bis<(t-butyldimethylsilyl)oxy>-9,10-secochola-5,7,10(19)-trien-24-al(135604-76-1)

Safety Data

• Hazardous Substances Data: 135604-76-1(Hazardous Substances Data)

Upstream product

• 18162-48-6 tert-butyldimethylsilyl chloride 
• 321911-18-6 (5Z,7E)-(1S,3R)-1,3-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-9,10-secochola-5,7,10⁽¹⁹⁾-triene-24-nitrile 
• 135604-82-9 (R)-4-{(1R,3aS,7aR)-4-[2-[(3S,5R)-3,5-Bis-(tert-butyl-dimethyl-silanyloxy)-2-methylene-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-7a-methyl-octahydro-inden-1-yl}-pentanoic acid methyl ester 
• 135604-81-8 methyl (5Z,7E)-(1S,3R)-1,3-dihydroxy-9,10-secochola-5,7,10-⁽¹⁹⁾-trien-24-oate 
• 135604-75-0 (5Z,7E)-(1S,3R)-1,3-bis<(t-butyldimethylsilyl)oxy>-9,10-secochola-5,7,10(19)-trien-24-ol 

Downstream Products

• 931110-83-7 (3S,8R)-4-Benzenesulfonyl-8-{(1R,3aS,7aR)-4-[2-[(3S,5R)-3,5-bis-(tert-butyl-dimethyl-silanyloxy)-2-methylene-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-7a-methyl-octahydro-inden-1-yl}-2,3-dimethyl-2-triethylsilanyloxy-nonan-5-ol 
• 931110-84-8 (3R,8R)-4-Benzenesulfonyl-8-{(1R,3aS,7aR)-4-[2-[(3S,5R)-3,5-bis-(tert-butyl-dimethyl-silanyloxy)-2-methylene-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-7a-methyl-octahydro-inden-1-yl}-2,3-dimethyl-2-triethylsilanyloxy-nonan-5-ol 
• 135604-70-5 PRI-2168 
• 135682-11-0 (24b S)-24,24-dihomo-1,25-dihydroxyergocalciferol 
• 135604-71-6 (24b R)-24,24-dihomo-1,25-dihydroxyergocalciferol 
• 321911-23-3 (5Z,7E)-(1S,3R)-1,3-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-24-(4-methylthiazol-2-yl)-9,10-secochola-5,7,10⁽¹⁹⁾-trien-24-ol 
• 321911-31-3 (5Z,7E)-(1S,3R)-1,3-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-24-(4-methylthien-2-yl)-9,10-secochola-5,7,10⁽¹⁹⁾-trien-24-ol 
• 321911-19-7 (5Z,7E)-(1S,3R)-1,3-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-24-(thiazol-2-yl)-9,10-secochola-5,7,10⁽¹⁹⁾-trien-24-ol 
• 931110-82-6 (R)-4-Benzenesulfonyl-8-{(1R,3aS,7aR)-4-[2-[(3S,5R)-3,5-bis-(tert-butyl-dimethyl-silanyloxy)-2-methylene-cyclohex-(Z)-ylidene]-eth-(E)-ylidene]-7a-methyl-octahydro-inden-1-yl}-2-methyl-2-triethylsilanyloxy-nonan-5-ol 

Relevant articles and documents

Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents

The invention relates to vitamin D derivatives of general formula I, process for their production, intermediate products of the process as well as the use for the production of pharmaceutical agents.